鈣網蛋白經由多腺嘌呤-尿嘧啶序列調控膀胱癌細胞J82之alpha(1,2)-岩藻醣轉移酶表達

Calreticulin Regulates Fucosyltransferase 1 Expression in Bladder Cancer Cell through A-U rich Element of 3’UTR

林翠華(Tsui-Hwa Lin)

指導教授 ： 李心予

國立臺灣大學/生命科學院/動物學研究所/碩士(2011年)

https://doi.org/10.6342/NTU.2011.00847

摘要

無資料

關鍵字

鈣網蛋白 ； 多腺嘌呤-尿嘧啶序列 ； alpha(1,2)-岩藻醣轉移酶

並列摘要

Calreticulin (CRT) localizes to intracellular, cell surface and extracellular compartments and regulates a variety of diverse and important biological processes. CRT ensures proper folding of proteins and glycoproteins regulating homeostatic control of cytosolic and ER calcium levels. CRT is necessary for cell adhesion, migration and phagocytosis of apoptotic cells.
CRT can be detected in urine of bladder cancer patients as a cancer marker. Higher concentration of urinary CRT tends to increase pathologic stages of tumor. Down-regulation of CRT suppresses tumor growth and metastatic capacities in human bladder cancer. Glycosylation of integrin modulates the binding strength of integrin and extracellular matrix (ECM) binding. Fucosyltransferase 1 (FUT1) expression and fucosylation of β1 integrin, catalyzed by FUT1, were down-regulated when CRT in human bladder cancer cells was knocked down (data unpublished). Suppression of FUT1 expression and fucosylation of β1 integrin may lead to modulation of tumor cell attachment and tumor malignances. Real-time PCR and mRNA degradation assays have indicated that half-life of FUT1 mRNA is much shorter in bladder cancer cells transfected with CRT-RNAi than in the control cells. These data implicated that the suppression of FUT1 expression might due to instability of FUT1 mRNA. In this
IV
study, we built EGFP-FUT1 3’UTR constructions with wild type adenylate-uridin rich element (ARE), mutated ARE and deleted ARE respectively. By transfecting each of these three constructions in J82 bladder cancer cells, we found that CRT plays a crucial role in modulating FUT1 mRNA stability through interacting with ARE in 3’UTR of FUT1 mRNA.

並列關鍵字

Calreticulin ； A-U rich Element ； Fucosyltransferase 1

參考文獻

1. Chen PC, Tsai MH, Yip SK, Jou YC, Ng CF, Chen Y, Wang X, Huang W, Tung CL, Chen GC et al: Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine. BMC Med Genomics 2011, 4:45.

2. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M et al: Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Science 2004, 95(12):955-961.

3. Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, Kotani K, Yoshimura K, Terai A, Arai Y, Yoshiki T: Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clinical Chemistry 2004, 50(5):857-866.

4. Lu YC, Chen CN, Wang B, Hsu WM, Chen ST, Chang KJ, Chang CC, Lee H: Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression. Am J Pathol 2011, 179(3):1425-1433.

5. Bedard K, Szabo E, Michalak M, Opas M: Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 2005, 245:91-121.